GENE ONLINE|News &
Opinion
Blog

Alexion Pharmaceuticals
Alexion Snaps Up LogicBio Seeking Expansion into Genomic Medicines
2022-10-03
China’s CANbridge Reports Positive Phase 1 Data of Contender to AstraZeneca’s Complement Inhibitor
2022-02-08
AstraZeneca Acquires Caelum in $500m Deal to Strengthen Rare Diseases Division
2021-09-30
BridgeBio Bags First FDA Nod with Rare Disease Drug Acquired from Alexion
2021-03-03
GeneOnline’s Top Mergers and Acquisitions of 2020
2020-12-30
AstraZeneca to Acquire Alexion for US$ 39 Billion to Grow Immunology Pipeline
2020-12-13
Taiwanese Government Grants 16 Million to aid Adimmune’s COVID-19 Vaccine Trials
2020-10-24
Efforts Behind the Taiwan Model of Combating COVID-19 Pandemic
2020-07-26Partner
Weekly in Asia|Nov-1
2019-11-19
LATEST
BIO 2023 Coming to Boston, with Over 60 Taiwanese Organizations to Share their Achievements
2023-06-02
2023 ASGCT Annual Meeting: Showcase of Exciting New Research, with a Focus on Clinical Applications
2023-06-02
Pfizer’s RSV Vaccine Gets FDA Approval for Use in Older Adults
2023-05-31
Brazil’s Evolving ESG Landscape from the Amazon to Atlantic Forest
2023-05-31
Should People Looking to Lose Weight Skip Sugar Substitutes?
2023-05-30
Advancing Next-Generation Cancer Metabolic Therapy by Targeting Critical Amino Acid Metabolic Pathways: An Interview with Brian A. Van Tine, MD, PhD
2023-05-26
Rona Therapeutics, Keymed Biosciences Team Up To Develop siRNA Drugs For Kidney Disease
2023-05-25
Scroll to Top